News on Sciele Pharma from BioPortfolio.com http://www.BioPortfolio.com Consolidated Sciele Pharma news from BioPortfolio.com Wed, 10 Feb 2010 02:48:42 GMT en Sciele Pharma, Inc.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019656&HITNO=0&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019656&THISHREF=http://c.moreover.com/click/here.pl%3fz2526428606%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4019656&HITNO=0&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4019656&THISHREF=http://c.moreover.com/click/here.pl%3fz2526428606%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Industry Leader Magdalena M. Alfano Added to the Cambridge Who's Who Networkhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006384&HITNO=1&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006384&THISHREF=http://c.moreover.com/click/here.pl%3fz2520701109%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006384&HITNO=1&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006384&THISHREF=http://c.moreover.com/click/here.pl%3fz2520701109%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com24-7PressRelease.com: Shionogi Supports Efforts for Haiti Earthquake Victimshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979099&HITNO=2&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979099&THISHREF=http://c.moreover.com/click/here.pl%3fz2505646568%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3979099&HITNO=2&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3979099&THISHREF=http://c.moreover.com/click/here.pl%3fz2505646568%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: FDA approvals of 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=3&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=3&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954214&HITNO=4&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954214&THISHREF=http://c.moreover.com/click/here.pl%3fz2492556466%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954214&HITNO=4&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954214&THISHREF=http://c.moreover.com/click/here.pl%3fz2492556466%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954142&HITNO=5&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954142&THISHREF=http://c.moreover.com/click/here.pl%3fz2492483248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954142&HITNO=5&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954142&THISHREF=http://c.moreover.com/click/here.pl%3fz2492483248%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945695&HITNO=6&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945695&THISHREF=http://c.moreover.com/click/here.pl%3fz2487262590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3945695&HITNO=6&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3945695&THISHREF=http://c.moreover.com/click/here.pl%3fz2487262590%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943101&HITNO=7&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943101&THISHREF=http://c.moreover.com/click/here.pl%3fz2485999250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943101&HITNO=7&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943101&THISHREF=http://c.moreover.com/click/here.pl%3fz2485999250%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Car...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942993&HITNO=8&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942993&THISHREF=http://c.moreover.com/click/here.pl%3fz2485966364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942993&HITNO=8&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942993&THISHREF=http://c.moreover.com/click/here.pl%3fz2485966364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942696&HITNO=9&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942696&THISHREF=http://c.moreover.com/click/here.pl%3fz2485843949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942696&HITNO=9&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942696&THISHREF=http://c.moreover.com/click/here.pl%3fz2485843949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942580&HITNO=10&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942580&THISHREF=http://c.moreover.com/click/here.pl%3fz2485797228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942580&HITNO=10&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942580&THISHREF=http://c.moreover.com/click/here.pl%3fz2485797228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobe Investor: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943143&HITNO=11&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943143&THISHREF=http://c.moreover.com/click/here.pl%3fz2486016445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3943143&HITNO=11&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3943143&THISHREF=http://c.moreover.com/click/here.pl%3fz2486016445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942606&HITNO=12&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942606&THISHREF=http://c.moreover.com/click/here.pl%3fz2485809582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942606&HITNO=12&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942606&THISHREF=http://c.moreover.com/click/here.pl%3fz2485809582%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942609&HITNO=13&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942609&THISHREF=http://c.moreover.com/click/here.pl%3fz2485810285%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3942609&HITNO=13&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3942609&THISHREF=http://c.moreover.com/click/here.pl%3fz2485810285%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Reliv International offers fundamental tips to prevent heart diseasehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933538&HITNO=14&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933538&THISHREF=http://c.moreover.com/click/here.pl%3fz2481770315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3933538&HITNO=14&MSIZE=52&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Sciele%20Pharma&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3933538&THISHREF=http://c.moreover.com/click/here.pl%3fz2481770315%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: